InSitu
SIRO™
Sirolimus-Eluting Stent
The Siro Drug Eluting Stent combines the U.S. patented Direct-Stent® design, the proven success of Sirolimus drug to reduce tissue ingrowth and proliferation, leading to reduced restenosis.
Contact ViettuongMedic for support
(+8428) 3811 5622
PRODUCT AT A GLANCE
Quality-Focused Engineering with FDA approval.
- Trusted and tested strength of a hybrid cell design.
- Patented and proven Direct-Stent platform.
- Clinically proven bioabsorbable polymer.
- Crimped profile 0.9 – 1.2mm.
- Semi-compliant balloon material.
- Results driven Sirolimus drug
- Rapid Exchange delivery system.
SPECIFICATIONS
- Material: Cobalt Chromium L605
- Sirolimus drug with dose of 2.0μg/mm2
- Polymer Proteqtor™ with high biodegradability
- Stent strut thickness: 80µm
- Tip profile: 0.017"
- Nominal pressure: 6 bar; Rated burst pressure: 16 bar
- Diameter range: Ø2.25 - 4.5mm
- Stent length: 10 - 48mm